APO Research, Inc.

Global Biological Sample Cryopreservation Market Analysis and Forecast 2026-2032

Choose your research edition.

Compare the research focus and single-user price for each edition.
Research editionIndustry ResearchIndustry Growth & TrendsMarket StructureMarket Outlook & Growth OpportunitiesMarket Analysis & ForecastSelected
Core differenceUnderstand the overall industry landscape, competition and leading companies.Examine growth drivers and how demand is developing across regional markets.Compare how the market is divided across companies, types and applications.Compare regional and country-level demand to assess geographic market opportunities.Assess market size, historical trends and forecasts for forward planning.
Single-user price$2,950 USD$3,450 USD$3,950 USD$4,250 USD$4,950 USD
Your choiceView editionView editionView editionView editionCurrent edition
View pricing & licenses

Biological Sample Cryopreservation encompasses the controlled freezing, vitrification, and cryogenic storage technologies used to preserve living cells, tissues, reproductive materials, microorganisms, and temperature sensitive biological specimens for subsequent recovery, analysis, or biological use. The underlying preservation mechanism involves reducing molecular mobility, enzymatic activity, and biochemical degradation at ultralow temperatures while limiting structural and functional damage associated with ice crystallization, osmotic imbalance, solute concentration, and membrane disruption. Conventional slow freezing applies controlled cooling rates to promote extracellular ice formation and cellular dehydration while reducing intracellular ice formation. Vitrification uses higher cryoprotectant concentrations and rapid temperature transitions to produce an amorphous solid state with minimal ice crystallization. Cryoprotective formulations incorporate permeating agents such as dimethyl sulfoxide, glycerol, and ethylene glycol, together with nonpermeating sugars, buffering systems, and other formulation components selected according to sample characteristics and freezing methods. Preservation performance depends on the interaction between cooling rate, cryoprotectant composition, sample volume, thermal history, storage temperature, and subsequent warming conditions.

Commercial cryopreservation technologies include programmable controlled rate freezers, mechanical ultralow temperature and cryogenic freezers, liquid nitrogen storage systems, automated cryogenic sample repositories, and specialized cryopreservation media. Equipment configurations incorporate cascade refrigeration circuits, liquid nitrogen cooling and distribution assemblies, vacuum insulated stainless steel vessels, thermal control systems, and automated sample handling mechanisms. Mechanical freezers operating near minus 80°C accommodate biological materials with compatible storage requirements, while systems operating near minus 150°C and liquid nitrogen environments approaching minus 196°C are used for extended preservation of viable cellular specimens. Cryogenic storage may employ liquid phase or nitrogen vapor phase configurations, with storage architecture determined by sample characteristics, thermal stability requirements, and contamination considerations. Commercial applications encompass biological sample repositories, biomedical research, biopharmaceutical cell banking and manufacturing, cell and gene therapy, assisted reproduction, clinical specimen preservation, and animal breeding. The product market covers dedicated freezing and cryogenic storage equipment and formulated cryopreservation media used directly in biological preservation. Independent storage and logistics services, general laboratory refrigeration, standalone sample packaging consumables, and unrelated laboratory equipment fall outside the product revenue boundary.

Product & engineering

Understand the product.

Biological Sample Cryopreservation encompasses the controlled freezing, vitrification, and cryogenic storage technologies used to preserve living cells, tissues, reproductive materials, microorganisms, and temperature sensitive biological specimens for subsequent recovery, analysis, or biological use. The underlying preservation mechanism involves reducing molecular mobility, enzymatic activity, and biochemical degradation at ultralow temperatures while limiting structural and functional damage associated with ice crystallization, osmotic imbalance, solute concentration, and membrane disruption. Conventional slow freezing applies controlled cooling rates to promote extracellular ice formation and cellular dehydration while reducing intracellular ice formation. Vitrification uses higher cryoprotectant concentrations and rapid temperature transitions to produce an amorphous solid state with minimal ice crystallization. Cryoprotective formulations incorporate permeating agents such as dimethyl sulfoxide, glycerol, and ethylene glycol, together with nonpermeating sugars, buffering systems, and other formulation components selected according to sample characteristics and freezing methods. Preservation performance depends on the interaction between cooling rate, cryoprotectant composition, sample volume, thermal history, storage temperature, and subsequent warming conditions.

Commercial cryopreservation technologies include programmable controlled rate freezers, mechanical ultralow temperature and cryogenic freezers, liquid nitrogen storage systems, automated cryogenic sample repositories, and specialized cryopreservation media. Equipment configurations incorporate cascade refrigeration circuits, liquid nitrogen cooling and distribution assemblies, vacuum insulated stainless steel vessels, thermal control systems, and automated sample handling mechanisms. Mechanical freezers operating near minus 80°C accommodate biological materials with compatible storage requirements, while systems operating near minus 150°C and liquid nitrogen environments approaching minus 196°C are used for extended preservation of viable cellular specimens. Cryogenic storage may employ liquid phase or nitrogen vapor phase configurations, with storage architecture determined by sample characteristics, thermal stability requirements, and contamination considerations. Commercial applications encompass biological sample repositories, biomedical research, biopharmaceutical cell banking and manufacturing, cell and gene therapy, assisted reproduction, clinical specimen preservation, and animal breeding. The product market covers dedicated freezing and cryogenic storage equipment and formulated cryopreservation media used directly in biological preservation. Independent storage and logistics services, general laboratory refrigeration, standalone sample packaging consumables, and unrelated laboratory equipment fall outside the product revenue boundary.

Selected research

Market Analysis & Forecast

Global Biological Sample Cryopreservation Market Analysis and Forecast 2026-2032

MARKET AT A GLANCE

Scale & outlook

2024
≈ 860USD million
2032
3,057.45USD million
Market size · USD million
02,0004,0002024 · Approx. 860 USD million≈ 86020242025 · Approx. 1,812.4 USD million≈ 1,812.420252026 · 1,933.15 USD million1,933.1520262032 · 3,057.45 USD million3,057.452032

Select a bar to inspect its value.

Source: APO Research, Inc.

Market perspective

According to APO Research, Inc, the global Biological Sample Cryopreservation market was valued at approximately USD 1,812.4 million in 2025 and is projected to reach USD 1,933.15 million in 2026 and USD 3,057.45 million by 2032, representing a compound annual growth rate (CAGR) of 7.94% from 2026 to 2032. Market revenue comprises dedicated controlled rate freezing equipment, ultralow temperature and cryogenic storage systems, automated biological sample repositories, and commercial cryopreservation media. Growth is driven by expanding biological specimen inventories, increased production of cell based therapeutics, and replacement of aging laboratory storage equipment. Equipment revenue depends on new installations, replacement cycles, and average selling prices, while cryopreservation media consumption follows the number of biological samples and cell manufacturing batches processed. Automated liquid nitrogen storage systems increase equipment expenditure per installation where sample capacity, retrieval frequency, and handling requirements justify additional capital investment.

Ultralow temperature freezers represent an established component of biological sample storage infrastructure. PHC Group estimated the global ultralow temperature freezer market at approximately USD 860 million in 2024 and identified emerging replacement demand for energy efficient equipment among pharmaceutical manufacturers and contract development and manufacturing organizations. Research institutions and biobanks face similar requirements as existing freezer fleets age and electricity consumption becomes a larger component of operating expenditure. In China, Haier Biomedical manufactures ultralow temperature storage equipment in Qingdao and intelligent liquid nitrogen storage systems in Chengdu, providing domestic manufacturing capacity across conventional and cryogenic storage technologies. Equipment demand in China and other Asian markets is influenced by biological sample repository development, pharmaceutical manufacturing investment, and the adoption of automated storage systems. North America, Europe, and Japan additionally generate replacement demand from established laboratory and biopharmaceutical infrastructure. Conventional freezer pricing remains subject to manufacturer competition, while automated cryogenic installations carry higher equipment values associated with insulated storage vessels, robotic handling, monitoring, and temperature management systems.

Cryogenic storage equipment and specialized preservation media are also influenced by the commercialization of advanced therapies and reproductive technologies. Cryoport reported USD 79.68 million in Life Sciences Products revenue in 2025, an increase of 6.6%, with stronger product demand in Europe, the Middle East, Africa, and Asia Pacific, alongside animal health applications in the Americas. Its product revenue includes cryogenic storage and transport equipment, reflecting demand from biological repositories, reproductive material preservation, and commercial cell therapy supply chains. BioLife Solutions reported USD 96.2 million in 2025 revenue, with biopreservation media accounting for approximately 87% of its business, including cryogenic freezing and hypothermic preservation formulations. Repligen completed its acquisition of BioLife Solutions in October 2026, adding the CryoStor cryopreservation media family to its bioprocessing business. As cell therapies advance from clinical development into commercial manufacturing, repeated production batches and frozen cellular inventories increase consumption of qualified freezing formulations. Cryoprotectant composition, post thaw cell recovery, and manufacturing process compatibility influence product selection and limit rapid substitution of established formulations. The market outlook consequently reflects continued equipment installations and replacements, a rising contribution from automated cryogenic storage, and recurring preservation media purchases tied to biological manufacturing activity.

Full market overview

Report Includes

This report presents an overview of global market for Biological Sample Cryopreservation, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biological Sample Cryopreservation, also provides the revenue of main regions and countries. Of the upcoming market potential for Biological Sample Cryopreservation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biological Sample Cryopreservation revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biological Sample Cryopreservation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biological Sample Cryopreservation revenue, projected growth trends, production technology, application and end-user industry.

Biological Sample Cryopreservation Segment by Company

  • Thermo Fisher Scientific
  • Haier Biomedical
  • PHCbi
  • Repligen
  • Cryoport
  • Azenta Life Sciences
  • Cytiva
  • Sartorius
  • FUJIFILM Biosciences
  • Lonza
  • Corning
  • Eppendorf
  • Greiner
  • SARSTEDT
  • Terumo
  • CooperSurgical
  • Vitrolife
  • Nexpring Health
  • Macopharma
  • Miltenyi Biotec
  • STEMCELL Technologies
  • Kitazato
  • Zhongke Meiling Cryogenics
  • AUCMA
  • BIOBASE
  • Genepoint Technologies
  • Origincell Biological Cryo Equipment
  • Basecare Medical
  • Hamilton Company
  • LiCONiC
  • ASKION
  • SPT Labtech
  • B Medical Systems
  • Custom Biogenic Systems
  • IC Biomedical
  • Cryo Bio System
  • Stirling Ultracold
  • Helmer Scientific
  • Micronic
  • OriGen Biomedical
  • BINDER
  • Liebherr
  • Esco Lifesciences
  • Cryopal
  • Cryotherm
  • Cryo Diffusion
  • Statebourne Cryogenics
  • Celltrio
  • ThermoGenesis
  • Jiangsu SERLNG
  • SYLAB
  • Consarctic
  • PromoCell
  • FertiPro
  • CryoLogic
  • Cryofab

Biological Sample Cryopreservation Segment by Type

  • Cryopreservation Equipment
  • Cryopreservation Media & Reagents
  • Cryopreservation Containers & Accessories
  • Cryopreservation Services

Biological Sample Cryopreservation Segment by Application

  • Biobanking
  • Biomedical Research
  • Biopharmaceutical Manufacturing
  • Cell & Gene Therapy
  • Assisted Reproduction
  • Clinical Diagnostics
  • Animal Breeding

Biological Sample Cryopreservation Segment by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Spain
    • Netherlands
    • Switzerland
    • Sweden
    • Poland
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Southeast Asia
  • South America
    • Brazil
    • Argentina
    • Chile
    • Colombia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Türkiye
    • GCC Countries

Study Objectives

  1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
  2. To present the key players, revenue, market share, and Recent Developments.
  3. To split the breakdown data by regions, type, manufacturers, and Application.
  4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
  5. To identify significant trends, drivers, influence factors in global and regions.
  6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

  1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Sample Cryopreservation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  2. This report will help stakeholders to understand the global industry status and trends of Biological Sample Cryopreservation and provides them with information on key market drivers, restraints, challenges, and opportunities.
  3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
  4. This report stays updated with novel technology integration, features, and the latest developments in the market.
  5. This report helps stakeholders to gain insights into which regions to target globally.
  6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Sample Cryopreservation.
  7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

  1. Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  2. Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  3. Chapter 3: Revenue of Biological Sample Cryopreservation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  4. Chapter 4: Detailed analysis of Biological Sample Cryopreservation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  5. Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  6. Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  7. Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biological Sample Cryopreservation revenue, gross margin, and recent development, etc.
  8. Chapter 8: North America by Type, by Application and by country, revenue for each segment.
  9. Chapter 9: Europe by Type, by Application and by country, revenue for each segment.
  10. Chapter 10: China type, by Application, revenue for each segment.
  11. Chapter 11: Asia (excluding China) type, by Application and by region, revenue for each segment.
  12. Chapter 12: South America, Middle East and Africa by Type, by Application and by country, revenue for each segment.
  13. Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures

List of Tables

  • Table 1. Global Biological Sample Cryopreservation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
  • Table 2. Cryopreservation Equipment Major Player
  • Table 3. Cryopreservation Media & Reagents Major Player
  • Table 4. Cryopreservation Containers & Accessories Major Player
  • Table 5. Cryopreservation Services Major Player
  • Table 6. Global Biological Sample Cryopreservation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
  • Table 7. Biobanking Major Player
  • Table 8. Biomedical Research Major Player
  • Table 9. Biopharmaceutical Manufacturing Major Player
  • Table 10. Cell & Gene Therapy Major Player
  • Table 11. Assisted Reproduction Major Player
  • Table 12. Clinical Diagnostics Major Player
  • Table 13. Animal Breeding Major Player
  • Table 14. Biological Sample Cryopreservation Industry Trends
  • Table 15. Biological Sample Cryopreservation Industry Drivers
  • Table 16. Biological Sample Cryopreservation Industry Opportunities and Challenges
  • Table 17. Biological Sample Cryopreservation Industry Restraints
  • Table 18. Global Biological Sample Cryopreservation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
  • Table 19. Global Biological Sample Cryopreservation Market Size by Region (2021-2026) & (US$ Million)
  • Table 20. Global Biological Sample Cryopreservation Market Share by Region (2021-2026)
  • Table 21. Global Biological Sample Cryopreservation Market Size by Region (2027-2032) & (US$ Million)
  • Table 22. Global Biological Sample Cryopreservation Market Share by Region (2027-2032)
  • Table 23. Global Biological Sample Cryopreservation Revenue by Players (US$ Million) & (2021-2026)
  • Table 24. Global Biological Sample Cryopreservation Revenue Market Share by Players (2021-2026)
  • Table 25. Global Biological Sample Cryopreservation Key Players Ranking, 2024 VS 2025 VS 2026
  • Table 26. Global Biological Sample Cryopreservation Key Players Headquarters & Area Served
  • Table 27. Global Biological Sample Cryopreservation Players, Product Type & Application
  • Table 28. Global Biological Sample Cryopreservation Players Establishment Date
  • Table 29. Global Players Market Concentration Ratio (CR5 and HHI)
  • Table 30. Global Biological Sample Cryopreservation by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
  • Table 31. Global Biological Sample Cryopreservation Revenue by Type 2021 VS 2025 VS 2032 (US$ Million)
  • Table 32. Global Biological Sample Cryopreservation Revenue by Type (2021-2026) & (US$ Million)
  • Table 33. Global Biological Sample Cryopreservation Revenue by Type (2027-2032) & (US$ Million)
  • Table 34. Global Biological Sample Cryopreservation Revenue Market Share by Type (2021-2026)
  • Table 35. Global Biological Sample Cryopreservation Revenue Market Share by Type (2027-2032)
  • Table 36. Global Biological Sample Cryopreservation Revenue by Application 2021 VS 2025 VS 2032 (US$ Million)
  • Table 37. Global Biological Sample Cryopreservation Revenue by Application (2021-2026) & (US$ Million)
  • Table 38. Global Biological Sample Cryopreservation Revenue by Application (2027-2032) & (US$ Million)
  • Table 39. Global Biological Sample Cryopreservation Revenue Market Share by Application (2021-2026)
  • Table 40. Global Biological Sample Cryopreservation Revenue Market Share by Application (2027-2032)
  • Table 41. Thermo Fisher Scientific Company Information
  • Table 42. Thermo Fisher Scientific Business Overview
  • Table 43. Thermo Fisher Scientific Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
  • Table 44. Thermo Fisher Scientific Biological Sample Cryopreservation Product Portfolio
  • Table 45. Thermo Fisher Scientific Recent Development
  • Table 46. Haier Biomedical Company Information
  • Table 47. Haier Biomedical Business Overview
  • Table 48. Haier Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
  • Table 49. Haier Biomedical Biological Sample Cryopreservation Product Portfolio
  • Table 50. Haier Biomedical Recent Development
  • Table 51. PHCbi Company Information
  • Table 52. PHCbi Business Overview
  • Table 53. PHCbi Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
  • Table 54. PHCbi Biological Sample Cryopreservation Product Portfolio
  • Table 55. PHCbi Recent Development
  • Table 56. Repligen Company Information
  • Table 57. Repligen Business Overview
  • Table 58. Repligen Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
  • Table 59. Repligen Biological Sample Cryopreservation Product Portfolio
  • Table 60. Repligen Recent Development
  • Table 61. Cryoport Company Information
  • Table 62. Cryoport Business Overview
  • Table 63. Cryoport Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
  • Table 64. Cryoport Biological Sample Cryopreservation Product Portfolio
  • Table 65. Cryoport Recent Development
  • Table 66. Azenta Life Sciences Company Information
  • Table 67. Azenta Life Sciences Business Overview
  • Table 68. Azenta Life Sciences Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
  • Table 69. Azenta Life Sciences Biological Sample Cryopreservation Product Portfolio
  • Table 70. Azenta Life Sciences Recent Development
  • Table 71. Cytiva Company Information
  • Table 72. Cytiva Business Overview
  • Table 73. Cytiva Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
  • Table 74. Cytiva Biological Sample Cryopreservation Product Portfolio
  • Table 75. Cytiva Recent Development
  • Table 76. Sartorius Company Information
  • Table 77. Sartorius Business Overview
  • Table 78. Sartorius Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
  • Table 79. Sartorius Biological Sample Cryopreservation Product Portfolio
  • Table 80. Sartorius Recent Development
  • Table 81. FUJIFILM Biosciences Company Information
  • Table 82. FUJIFILM Biosciences Business Overview
  • Table 83. FUJIFILM Biosciences Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
  • Table 84. FUJIFILM Biosciences Biological Sample Cryopreservation Product Portfolio
  • Table 85. FUJIFILM Biosciences Recent Development
  • Table 86. Lonza Company Information
  • Table 87. Lonza Business Overview
  • Table 88. Lonza Biological Sample Cryopreservation Revenue and Gross Margin (US$ Million) & (2021-2026)
  • Table 89. Lonza Biological Sample Cryopreservation Product Portfolio
  • Table 90. Lonza Recent Development
  • Table 91. Corning Company Information
  • Table 92. Corning Business Overview
  • Table 93. Corning Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 94. Corning Biological Sample Cryopreservation Product Portfolio
  • Table 95. Corning Recent Development
  • Table 96. Eppendorf Company Information
  • Table 97. Eppendorf Business Overview
  • Table 98. Eppendorf Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 99. Eppendorf Biological Sample Cryopreservation Product Portfolio
  • Table 100. Eppendorf Recent Development
  • Table 101. Greiner Company Information
  • Table 102. Greiner Business Overview
  • Table 103. Greiner Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 104. Greiner Biological Sample Cryopreservation Product Portfolio
  • Table 105. Greiner Recent Development
  • Table 106. SARSTEDT Company Information
  • Table 107. SARSTEDT Business Overview
  • Table 108. SARSTEDT Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 109. SARSTEDT Biological Sample Cryopreservation Product Portfolio
  • Table 110. SARSTEDT Recent Development
  • Table 111. Terumo Company Information
  • Table 112. Terumo Business Overview
  • Table 113. Terumo Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 114. Terumo Biological Sample Cryopreservation Product Portfolio
  • Table 115. Terumo Recent Development
  • Table 116. CooperSurgical Company Information
  • Table 117. CooperSurgical Business Overview
  • Table 118. CooperSurgical Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 119. CooperSurgical Biological Sample Cryopreservation Product Portfolio
  • Table 120. CooperSurgical Recent Development
  • Table 121. Vitrolife Company Information
  • Table 122. Vitrolife Business Overview
  • Table 123. Vitrolife Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 124. Vitrolife Biological Sample Cryopreservation Product Portfolio
  • Table 125. Vitrolife Recent Development
  • Table 126. Nexpring Health Company Information
  • Table 127. Nexpring Health Business Overview
  • Table 128. Nexpring Health Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 129. Nexpring Health Biological Sample Cryopreservation Product Portfolio
  • Table 130. Nexpring Health Recent Development
  • Table 131. Macopharma Company Information
  • Table 132. Macopharma Business Overview
  • Table 133. Macopharma Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 134. Macopharma Biological Sample Cryopreservation Product Portfolio
  • Table 135. Macopharma Recent Development
  • Table 136. Miltenyi Biotec Company Information
  • Table 137. Miltenyi Biotec Business Overview
  • Table 138. Miltenyi Biotec Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 139. Miltenyi Biotec Biological Sample Cryopreservation Product Portfolio
  • Table 140. Miltenyi Biotec Recent Development
  • Table 141. STEMCELL Technologies Company Information
  • Table 142. STEMCELL Technologies Business Overview
  • Table 143. STEMCELL Technologies Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 144. STEMCELL Technologies Biological Sample Cryopreservation Product Portfolio
  • Table 145. STEMCELL Technologies Recent Development
  • Table 146. Kitazato Company Information
  • Table 147. Kitazato Business Overview
  • Table 148. Kitazato Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 149. Kitazato Biological Sample Cryopreservation Product Portfolio
  • Table 150. Kitazato Recent Development
  • Table 151. Zhongke Meiling Cryogenics Company Information
  • Table 152. Zhongke Meiling Cryogenics Business Overview
  • Table 153. Zhongke Meiling Cryogenics Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 154. Zhongke Meiling Cryogenics Biological Sample Cryopreservation Product Portfolio
  • Table 155. Zhongke Meiling Cryogenics Recent Development
  • Table 156. AUCMA Company Information
  • Table 157. AUCMA Business Overview
  • Table 158. AUCMA Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 159. AUCMA Biological Sample Cryopreservation Product Portfolio
  • Table 160. AUCMA Recent Development
  • Table 161. BIOBASE Company Information
  • Table 162. BIOBASE Business Overview
  • Table 163. BIOBASE Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 164. BIOBASE Biological Sample Cryopreservation Product Portfolio
  • Table 165. BIOBASE Recent Development
  • Table 166. Genepoint Technologies Company Information
  • Table 167. Genepoint Technologies Business Overview
  • Table 168. Genepoint Technologies Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 169. Genepoint Technologies Biological Sample Cryopreservation Product Portfolio
  • Table 170. Genepoint Technologies Recent Development
  • Table 171. Origincell Biological Cryo Equipment Company Information
  • Table 172. Origincell Biological Cryo Equipment Business Overview
  • Table 173. Origincell Biological Cryo Equipment Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 174. Origincell Biological Cryo Equipment Biological Sample Cryopreservation Product Portfolio
  • Table 175. Origincell Biological Cryo Equipment Recent Development
  • Table 176. Basecare Medical Company Information
  • Table 177. Basecare Medical Business Overview
  • Table 178. Basecare Medical Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 179. Basecare Medical Biological Sample Cryopreservation Product Portfolio
  • Table 180. Basecare Medical Recent Development
  • Table 181. Hamilton Company Company Information
  • Table 182. Hamilton Company Business Overview
  • Table 183. Hamilton Company Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 184. Hamilton Company Biological Sample Cryopreservation Product Portfolio
  • Table 185. Hamilton Company Recent Development
  • Table 186. LiCONiC Company Information
  • Table 187. LiCONiC Business Overview
  • Table 188. LiCONiC Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 189. LiCONiC Biological Sample Cryopreservation Product Portfolio
  • Table 190. LiCONiC Recent Development
  • Table 191. ASKION Company Information
  • Table 192. ASKION Business Overview
  • Table 193. ASKION Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 194. ASKION Biological Sample Cryopreservation Product Portfolio
  • Table 195. ASKION Recent Development
  • Table 196. SPT Labtech Company Information
  • Table 197. SPT Labtech Business Overview
  • Table 198. SPT Labtech Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 199. SPT Labtech Biological Sample Cryopreservation Product Portfolio
  • Table 200. SPT Labtech Recent Development
  • Table 201. B Medical Systems Company Information
  • Table 202. B Medical Systems Business Overview
  • Table 203. B Medical Systems Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 204. B Medical Systems Biological Sample Cryopreservation Product Portfolio
  • Table 205. B Medical Systems Recent Development
  • Table 206. Custom Biogenic Systems Company Information
  • Table 207. Custom Biogenic Systems Business Overview
  • Table 208. Custom Biogenic Systems Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 209. Custom Biogenic Systems Biological Sample Cryopreservation Product Portfolio
  • Table 210. Custom Biogenic Systems Recent Development
  • Table 211. IC Biomedical Company Information
  • Table 212. IC Biomedical Business Overview
  • Table 213. IC Biomedical Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 214. IC Biomedical Biological Sample Cryopreservation Product Portfolio
  • Table 215. IC Biomedical Recent Development
  • Table 216. Cryo Bio System Company Information
  • Table 217. Cryo Bio System Business Overview
  • Table 218. Cryo Bio System Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 219. Cryo Bio System Biological Sample Cryopreservation Product Portfolio
  • Table 220. Cryo Bio System Recent Development
  • Table 221. Stirling Ultracold Company Information
  • Table 222. Stirling Ultracold Business Overview
  • Table 223. Stirling Ultracold Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 224. Stirling Ultracold Biological Sample Cryopreservation Product Portfolio
  • Table 225. Stirling Ultracold Recent Development
  • Table 226. Helmer Scientific Company Information
  • Table 227. Helmer Scientific Business Overview
  • Table 228. Helmer Scientific Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 229. Helmer Scientific Biological Sample Cryopreservation Product Portfolio
  • Table 230. Helmer Scientific Recent Development
  • Table 231. Micronic Company Information
  • Table 232. Micronic Business Overview
  • Table 233. Micronic Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 234. Micronic Biological Sample Cryopreservation Product Portfolio
  • Table 235. Micronic Recent Development
  • Table 236. OriGen Biomedical Company Information
  • Table 237. OriGen Biomedical Business Overview
  • Table 238. OriGen Biomedical Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 239. OriGen Biomedical Biological Sample Cryopreservation Product Portfolio
  • Table 240. OriGen Biomedical Recent Development
  • Table 241. BINDER Company Information
  • Table 242. BINDER Business Overview
  • Table 243. BINDER Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 244. BINDER Biological Sample Cryopreservation Product Portfolio
  • Table 245. BINDER Recent Development
  • Table 246. Liebherr Company Information
  • Table 247. Liebherr Business Overview
  • Table 248. Liebherr Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 249. Liebherr Biological Sample Cryopreservation Product Portfolio
  • Table 250. Liebherr Recent Development
  • Table 251. Esco Lifesciences Company Information
  • Table 252. Esco Lifesciences Business Overview
  • Table 253. Esco Lifesciences Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 254. Esco Lifesciences Biological Sample Cryopreservation Product Portfolio
  • Table 255. Esco Lifesciences Recent Development
  • Table 256. Cryopal Company Information
  • Table 257. Cryopal Business Overview
  • Table 258. Cryopal Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 259. Cryopal Biological Sample Cryopreservation Product Portfolio
  • Table 260. Cryopal Recent Development
  • Table 261. Cryotherm Company Information
  • Table 262. Cryotherm Business Overview
  • Table 263. Cryotherm Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 264. Cryotherm Biological Sample Cryopreservation Product Portfolio
  • Table 265. Cryotherm Recent Development
  • Table 266. Cryo Diffusion Company Information
  • Table 267. Cryo Diffusion Business Overview
  • Table 268. Cryo Diffusion Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 269. Cryo Diffusion Biological Sample Cryopreservation Product Portfolio
  • Table 270. Cryo Diffusion Recent Development
  • Table 271. Statebourne Cryogenics Company Information
  • Table 272. Statebourne Cryogenics Business Overview
  • Table 273. Statebourne Cryogenics Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 274. Statebourne Cryogenics Biological Sample Cryopreservation Product Portfolio
  • Table 275. Statebourne Cryogenics Recent Development
  • Table 276. Celltrio Company Information
  • Table 277. Celltrio Business Overview
  • Table 278. Celltrio Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 279. Celltrio Biological Sample Cryopreservation Product Portfolio
  • Table 280. Celltrio Recent Development
  • Table 281. ThermoGenesis Company Information
  • Table 282. ThermoGenesis Business Overview
  • Table 283. ThermoGenesis Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 284. ThermoGenesis Biological Sample Cryopreservation Product Portfolio
  • Table 285. ThermoGenesis Recent Development
  • Table 286. Jiangsu SERLNG Company Information
  • Table 287. Jiangsu SERLNG Business Overview
  • Table 288. Jiangsu SERLNG Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 289. Jiangsu SERLNG Biological Sample Cryopreservation Product Portfolio
  • Table 290. Jiangsu SERLNG Recent Development
  • Table 291. SYLAB Company Information
  • Table 292. SYLAB Business Overview
  • Table 293. SYLAB Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 294. SYLAB Biological Sample Cryopreservation Product Portfolio
  • Table 295. SYLAB Recent Development
  • Table 296. Consarctic Company Information
  • Table 297. Consarctic Business Overview
  • Table 298. Consarctic Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 299. Consarctic Biological Sample Cryopreservation Product Portfolio
  • Table 300. Consarctic Recent Development
  • Table 301. PromoCell Company Information
  • Table 302. PromoCell Business Overview
  • Table 303. PromoCell Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 304. PromoCell Biological Sample Cryopreservation Product Portfolio
  • Table 305. PromoCell Recent Development
  • Table 306. FertiPro Company Information
  • Table 307. FertiPro Business Overview
  • Table 308. FertiPro Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 309. FertiPro Biological Sample Cryopreservation Product Portfolio
  • Table 310. FertiPro Recent Development
  • Table 311. CryoLogic Company Information
  • Table 312. CryoLogic Business Overview
  • Table 313. CryoLogic Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 314. CryoLogic Biological Sample Cryopreservation Product Portfolio
  • Table 315. CryoLogic Recent Development
  • Table 316. Cryofab Company Information
  • Table 317. Cryofab Business Overview
  • Table 318. Cryofab Biological Sample Cryopreservation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 319. Cryofab Biological Sample Cryopreservation Product Portfolio
  • Table 320. Cryofab Recent Development
  • Table 321. North America Biological Sample Cryopreservation Revenue by Type (2021-2026) & (US$ Million)
  • Table 322. North America Biological Sample Cryopreservation Revenue by Type (2027-2032) & (US$ Million)
  • Table 323. North America Biological Sample Cryopreservation Revenue by Application (2021-2026) & (US$ Million)
  • Table 324. North America Biological Sample Cryopreservation Revenue by Application (2027-2032) & (US$ Million)
  • Table 325. North America Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
  • Table 326. North America Biological Sample Cryopreservation Revenue by Country (2021-2026) & (US$ Million)
  • Table 327. North America Biological Sample Cryopreservation Revenue by Country (US$ Million) & (2027-2032)
  • Table 328. Europe Biological Sample Cryopreservation Revenue by Type (2021-2026) & (US$ Million)
  • Table 329. Europe Biological Sample Cryopreservation Revenue by Type (2027-2032) & (US$ Million)
  • Table 330. Europe Biological Sample Cryopreservation Revenue by Application (2021-2026) & (US$ Million)
  • Table 331. Europe Biological Sample Cryopreservation Revenue by Application (2027-2032) & (US$ Million)
  • Table 332. Europe Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
  • Table 333. Europe Biological Sample Cryopreservation Revenue by Country (2021-2026) & (US$ Million)
  • Table 334. Europe Biological Sample Cryopreservation Revenue by Country (US$ Million) & (2027-2032)
  • Table 335. China Biological Sample Cryopreservation Revenue by Type (2021-2026) & (US$ Million)
  • Table 336. China Biological Sample Cryopreservation Revenue by Type (2027-2032) & (US$ Million)
  • Table 337. China Biological Sample Cryopreservation Revenue by Application (2021-2026) & (US$ Million)
  • Table 338. China Biological Sample Cryopreservation Revenue by Application (2027-2032) & (US$ Million)
  • Table 339. Asia Biological Sample Cryopreservation Revenue by Type (2021-2026) & (US$ Million)
  • Table 340. Asia Biological Sample Cryopreservation Revenue by Type (2027-2032) & (US$ Million)
  • Table 341. Asia Biological Sample Cryopreservation Revenue by Application (2021-2026) & (US$ Million)
  • Table 342. Asia Biological Sample Cryopreservation Revenue by Application (2027-2032) & (US$ Million)
  • Table 343. Asia Biological Sample Cryopreservation Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million)
  • Table 344. Asia Biological Sample Cryopreservation Revenue by Region (US$ Million) & (2021-2026)
  • Table 345. Asia Biological Sample Cryopreservation Revenue by Region (US$ Million) & (2027-2032)
  • Table 346. SAMEA Biological Sample Cryopreservation Revenue by Type (2021-2026) & (US$ Million)
  • Table 347. SAMEA Biological Sample Cryopreservation Revenue by Type (2027-2032) & (US$ Million)
  • Table 348. SAMEA Biological Sample Cryopreservation Revenue by Application (2021-2026) & (US$ Million)
  • Table 349. SAMEA Biological Sample Cryopreservation Revenue by Application (2027-2032) & (US$ Million)
  • Table 350. SAMEA Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
  • Table 351. SAMEA Biological Sample Cryopreservation Revenue by Country (2021-2026) & (US$ Million)
  • Table 352. SAMEA Biological Sample Cryopreservation Revenue by Country (US$ Million) & (2027-2032)
  • Table 353. Research Programs/Design for This Report
  • Table 354. Authors List of This Report
  • Table 355. Secondary Sources
  • Table 356. Primary Sources

List of Figures

  • Figure 1. Biological Sample Cryopreservation Image
  • Figure 2. Global Biological Sample Cryopreservation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
  • Figure 3. Global Biological Sample Cryopreservation Market Size Share 2021 VS 2025 VS 2032
  • Figure 4. Cryopreservation Equipment Image
  • Figure 5. Cryopreservation Media & Reagents Image
  • Figure 6. Cryopreservation Containers & Accessories Image
  • Figure 7. Cryopreservation Services Image
  • Figure 8. Global Biological Sample Cryopreservation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
  • Figure 9. Global Biological Sample Cryopreservation Market Size Share 2021 VS 2025 VS 2032
  • Figure 10. Biobanking Image
  • Figure 11. Biomedical Research Image
  • Figure 12. Biopharmaceutical Manufacturing Image
  • Figure 13. Cell & Gene Therapy Image
  • Figure 14. Assisted Reproduction Image
  • Figure 15. Clinical Diagnostics Image
  • Figure 16. Animal Breeding Image
  • Figure 17. Global Biological Sample Cryopreservation Market Size (US$ Million) & (2021-2032)
  • Figure 18. Global Biological Sample Cryopreservation Market Size, (US$ Million), 2021 VS 2025 VS 2032
  • Figure 19. Global Biological Sample Cryopreservation Market Share by Region: 2021 VS 2025 VS 2032
  • Figure 20. Global Biological Sample Cryopreservation Players Revenue Share Top 10 and Top 5 in 2025
  • Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
  • Figure 22. Global Biological Sample Cryopreservation Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million)
  • Figure 23. Global Biological Sample Cryopreservation Revenue Market Share 2021 VS 2025 VS 2032
  • Figure 24. Global Biological Sample Cryopreservation Revenue Market Share by Type (2021-2032)
  • Figure 25. Global Biological Sample Cryopreservation Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million)
  • Figure 26. Global Biological Sample Cryopreservation Revenue Market Share by Application (2021 VS 2025 VS 2032)
  • Figure 27. Global Biological Sample Cryopreservation Revenue Market Share by Application (2021-2032)
  • Figure 28. North America Biological Sample Cryopreservation Revenue YoY Growth (2021-2032) & (US$ Million)
  • Figure 29. North America Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
  • Figure 30. North America Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
  • Figure 31. North America Biological Sample Cryopreservation Revenue Share by Country (2021-2032)
  • Figure 32. United States Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 33. Canada Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 34. Mexico Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 35. Europe Biological Sample Cryopreservation Revenue YoY Growth (2021-2032) & (US$ Million)
  • Figure 36. Europe Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
  • Figure 37. Europe Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
  • Figure 38. Europe Biological Sample Cryopreservation Revenue Share by Country (2021-2032)
  • Figure 39. Germany Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 40. France Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 41. U.K. Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 42. Italy Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 43. Spain Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 44. Russia Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 45. Netherlands Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 46. Nordic Countries Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 47. China Biological Sample Cryopreservation Revenue YoY Growth (2021-2032) & (US$ Million)
  • Figure 48. China Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
  • Figure 49. China Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
  • Figure 50. Asia Biological Sample Cryopreservation Revenue YoY Growth (2021-2032) & (US$ Million)
  • Figure 51. Asia Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
  • Figure 52. Asia Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
  • Figure 53. Asia Biological Sample Cryopreservation Revenue Share by Region (2021-2032)
  • Figure 54. Japan Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 55. South Korea Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 56. India Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 57. Australia Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 58. Taiwan Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 59. Southeast Asia Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 60. SAMEA Biological Sample Cryopreservation Revenue YoY Growth (2021-2032) & (US$ Million)
  • Figure 61. SAMEA Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
  • Figure 62. SAMEA Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
  • Figure 63. SAMEA Biological Sample Cryopreservation Revenue Share by Country (2021-2032)
  • Figure 64. Brazil Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 65. Argentina Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 66. Chile Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 67. Colombia Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 68. Peru Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 69. Saudi Arabia Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 70. Israel Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 71. UAE Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 72. Turkey Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 73. Iran Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 74. Egypt Biological Sample Cryopreservation Revenue YoY Growth (US$ Million) & (2021-2032)
  • Figure 75. Years Considered
  • Figure 76. Research Process
  • Figure 77. Key Executives Interviewed

Scope & coverage.

By Type
  • Cryopreservation Equipment
  • Cryopreservation Media & Reagents
  • Cryopreservation Containers & Accessories
  • Cryopreservation Services
By Application
  • Biobanking
  • Biomedical Research
  • Biopharmaceutical Manufacturing
  • Cell & Gene Therapy
  • Assisted Reproduction
  • Clinical Diagnostics
  • Animal Breeding
Companies covered
  • Thermo Fisher Scientific
  • Haier Biomedical
  • PHCbi
  • Repligen
  • Cryoport
  • Azenta Life Sciences
  • Cytiva
  • Sartorius
  • FUJIFILM Biosciences
  • Lonza
  • Corning
  • Eppendorf
  • Greiner
  • SARSTEDT
  • Terumo
  • CooperSurgical
  • Vitrolife
  • Nexpring Health
  • Macopharma
  • Miltenyi Biotec
  • STEMCELL Technologies
  • Kitazato
  • Zhongke Meiling Cryogenics
  • AUCMA
  • BIOBASE
  • Genepoint Technologies
  • Origincell Biological Cryo Equipment
  • Basecare Medical
  • Hamilton Company
  • LiCONiC
  • ASKION
  • SPT Labtech
  • B Medical Systems
  • Custom Biogenic Systems
  • IC Biomedical
  • Cryo Bio System
  • Stirling Ultracold
  • Helmer Scientific
  • Micronic
  • OriGen Biomedical
  • BINDER
  • Liebherr
  • Esco Lifesciences
  • Cryopal
  • Cryotherm
  • Cryo Diffusion
  • Statebourne Cryogenics
  • Celltrio
  • ThermoGenesis
  • Jiangsu SERLNG
  • SYLAB
  • Consarctic
  • PromoCell
  • FertiPro
  • CryoLogic
  • Cryofab

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biological Sample Cryopreservation Market by Type
  3. 1.2.1 Global Biological Sample Cryopreservation Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cryopreservation Equipment
  5. 1.2.3 Cryopreservation Media & Reagents
  6. 1.2.4 Cryopreservation Containers & Accessories
  7. 1.2.5 Cryopreservation Services
  8. 1.3 Biological Sample Cryopreservation Market by Application
  9. 1.3.1 Global Biological Sample Cryopreservation Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Biobanking
  11. 1.3.3 Biomedical Research
  12. 1.3.4 Biopharmaceutical Manufacturing
  13. 1.3.5 Cell & Gene Therapy
  14. 1.3.6 Assisted Reproduction
  15. 1.3.7 Clinical Diagnostics
  16. 1.3.8 Animal Breeding
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Biological Sample Cryopreservation Market Dynamics
  1. 2.1 Biological Sample Cryopreservation Industry Trends
  2. 2.2 Biological Sample Cryopreservation Industry Drivers
  3. 2.3 Biological Sample Cryopreservation Industry Opportunities and Challenges
  4. 2.4 Biological Sample Cryopreservation Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biological Sample Cryopreservation Market Perspective (2021-2032)
  2. 3.2 Global Biological Sample Cryopreservation Growth Trends by Region
  3. 3.2.1 Global Biological Sample Cryopreservation Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biological Sample Cryopreservation Market Size by Region (2021-2026)
  5. 3.2.3 Global Biological Sample Cryopreservation Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biological Sample Cryopreservation Revenue by Players
  2. 4.1.1 Global Biological Sample Cryopreservation Revenue by Players (2021-2026)
  3. 4.1.2 Global Biological Sample Cryopreservation Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biological Sample Cryopreservation Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biological Sample Cryopreservation Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biological Sample Cryopreservation Key Players Headquarters & Area Served
  7. 4.4 Global Biological Sample Cryopreservation Players, Product Type & Application
  8. 4.5 Global Biological Sample Cryopreservation Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biological Sample Cryopreservation Market CR5 and HHI
  11. 4.6.2 2025 Biological Sample Cryopreservation Tier 1, Tier 2, and Tier 3
5 Biological Sample Cryopreservation Market Size by Type
  1. 5.1 Global Biological Sample Cryopreservation Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biological Sample Cryopreservation Revenue by Type (2021-2032)
  3. 5.3 Global Biological Sample Cryopreservation Revenue Market Share by Type (2021-2032)
6 Biological Sample Cryopreservation Market Size by Application
  1. 6.1 Global Biological Sample Cryopreservation Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biological Sample Cryopreservation Revenue by Application (2021-2032)
  3. 6.3 Global Biological Sample Cryopreservation Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Biological Sample Cryopreservation Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Haier Biomedical
  8. 7.2.1 Haier Biomedical Company Information
  9. 7.2.2 Haier Biomedical Business Overview
  10. 7.2.3 Haier Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Haier Biomedical Biological Sample Cryopreservation Product Portfolio
  12. 7.2.5 Haier Biomedical Recent Developments
  13. 7.3 PHCbi
  14. 7.3.1 PHCbi Company Information
  15. 7.3.2 PHCbi Business Overview
  16. 7.3.3 PHCbi Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  17. 7.3.4 PHCbi Biological Sample Cryopreservation Product Portfolio
  18. 7.3.5 PHCbi Recent Developments
  19. 7.4 Repligen
  20. 7.4.1 Repligen Company Information
  21. 7.4.2 Repligen Business Overview
  22. 7.4.3 Repligen Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Repligen Biological Sample Cryopreservation Product Portfolio
  24. 7.4.5 Repligen Recent Developments
  25. 7.5 Cryoport
  26. 7.5.1 Cryoport Company Information
  27. 7.5.2 Cryoport Business Overview
  28. 7.5.3 Cryoport Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Cryoport Biological Sample Cryopreservation Product Portfolio
  30. 7.5.5 Cryoport Recent Developments
  31. 7.6 Azenta Life Sciences
  32. 7.6.1 Azenta Life Sciences Company Information
  33. 7.6.2 Azenta Life Sciences Business Overview
  34. 7.6.3 Azenta Life Sciences Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Azenta Life Sciences Biological Sample Cryopreservation Product Portfolio
  36. 7.6.5 Azenta Life Sciences Recent Developments
  37. 7.7 Cytiva
  38. 7.7.1 Cytiva Company Information
  39. 7.7.2 Cytiva Business Overview
  40. 7.7.3 Cytiva Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Cytiva Biological Sample Cryopreservation Product Portfolio
  42. 7.7.5 Cytiva Recent Developments
  43. 7.8 Sartorius
  44. 7.8.1 Sartorius Company Information
  45. 7.8.2 Sartorius Business Overview
  46. 7.8.3 Sartorius Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sartorius Biological Sample Cryopreservation Product Portfolio
  48. 7.8.5 Sartorius Recent Developments
  49. 7.9 FUJIFILM Biosciences
  50. 7.9.1 FUJIFILM Biosciences Company Information
  51. 7.9.2 FUJIFILM Biosciences Business Overview
  52. 7.9.3 FUJIFILM Biosciences Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  53. 7.9.4 FUJIFILM Biosciences Biological Sample Cryopreservation Product Portfolio
  54. 7.9.5 FUJIFILM Biosciences Recent Developments
  55. 7.10 Lonza
  56. 7.10.1 Lonza Company Information
  57. 7.10.2 Lonza Business Overview
  58. 7.10.3 Lonza Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Lonza Biological Sample Cryopreservation Product Portfolio
  60. 7.10.5 Lonza Recent Developments
  61. 7.11 Corning
  62. 7.11.1 Corning Company Information
  63. 7.11.2 Corning Business Overview
  64. 7.11.3 Corning Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Corning Biological Sample Cryopreservation Product Portfolio
  66. 7.11.5 Corning Recent Developments
  67. 7.12 Eppendorf
  68. 7.12.1 Eppendorf Company Information
  69. 7.12.2 Eppendorf Business Overview
  70. 7.12.3 Eppendorf Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Eppendorf Biological Sample Cryopreservation Product Portfolio
  72. 7.12.5 Eppendorf Recent Developments
  73. 7.13 Greiner
  74. 7.13.1 Greiner Company Information
  75. 7.13.2 Greiner Business Overview
  76. 7.13.3 Greiner Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Greiner Biological Sample Cryopreservation Product Portfolio
  78. 7.13.5 Greiner Recent Developments
  79. 7.14 SARSTEDT
  80. 7.14.1 SARSTEDT Company Information
  81. 7.14.2 SARSTEDT Business Overview
  82. 7.14.3 SARSTEDT Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  83. 7.14.4 SARSTEDT Biological Sample Cryopreservation Product Portfolio
  84. 7.14.5 SARSTEDT Recent Developments
  85. 7.15 Terumo
  86. 7.15.1 Terumo Company Information
  87. 7.15.2 Terumo Business Overview
  88. 7.15.3 Terumo Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Terumo Biological Sample Cryopreservation Product Portfolio
  90. 7.15.5 Terumo Recent Developments
  91. 7.16 CooperSurgical
  92. 7.16.1 CooperSurgical Company Information
  93. 7.16.2 CooperSurgical Business Overview
  94. 7.16.3 CooperSurgical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  95. 7.16.4 CooperSurgical Biological Sample Cryopreservation Product Portfolio
  96. 7.16.5 CooperSurgical Recent Developments
  97. 7.17 Vitrolife
  98. 7.17.1 Vitrolife Company Information
  99. 7.17.2 Vitrolife Business Overview
  100. 7.17.3 Vitrolife Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Vitrolife Biological Sample Cryopreservation Product Portfolio
  102. 7.17.5 Vitrolife Recent Developments
  103. 7.18 Nexpring Health
  104. 7.18.1 Nexpring Health Company Information
  105. 7.18.2 Nexpring Health Business Overview
  106. 7.18.3 Nexpring Health Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Nexpring Health Biological Sample Cryopreservation Product Portfolio
  108. 7.18.5 Nexpring Health Recent Developments
  109. 7.19 Macopharma
  110. 7.19.1 Macopharma Company Information
  111. 7.19.2 Macopharma Business Overview
  112. 7.19.3 Macopharma Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Macopharma Biological Sample Cryopreservation Product Portfolio
  114. 7.19.5 Macopharma Recent Developments
  115. 7.20 Miltenyi Biotec
  116. 7.20.1 Miltenyi Biotec Company Information
  117. 7.20.2 Miltenyi Biotec Business Overview
  118. 7.20.3 Miltenyi Biotec Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Miltenyi Biotec Biological Sample Cryopreservation Product Portfolio
  120. 7.20.5 Miltenyi Biotec Recent Developments
  121. 7.21 STEMCELL Technologies
  122. 7.21.1 STEMCELL Technologies Company Information
  123. 7.21.2 STEMCELL Technologies Business Overview
  124. 7.21.3 STEMCELL Technologies Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  125. 7.21.4 STEMCELL Technologies Biological Sample Cryopreservation Product Portfolio
  126. 7.21.5 STEMCELL Technologies Recent Developments
  127. 7.22 Kitazato
  128. 7.22.1 Kitazato Company Information
  129. 7.22.2 Kitazato Business Overview
  130. 7.22.3 Kitazato Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Kitazato Biological Sample Cryopreservation Product Portfolio
  132. 7.22.5 Kitazato Recent Developments
  133. 7.23 Zhongke Meiling Cryogenics
  134. 7.23.1 Zhongke Meiling Cryogenics Company Information
  135. 7.23.2 Zhongke Meiling Cryogenics Business Overview
  136. 7.23.3 Zhongke Meiling Cryogenics Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Zhongke Meiling Cryogenics Biological Sample Cryopreservation Product Portfolio
  138. 7.23.5 Zhongke Meiling Cryogenics Recent Developments
  139. 7.24 AUCMA
  140. 7.24.1 AUCMA Company Information
  141. 7.24.2 AUCMA Business Overview
  142. 7.24.3 AUCMA Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  143. 7.24.4 AUCMA Biological Sample Cryopreservation Product Portfolio
  144. 7.24.5 AUCMA Recent Developments
  145. 7.25 BIOBASE
  146. 7.25.1 BIOBASE Company Information
  147. 7.25.2 BIOBASE Business Overview
  148. 7.25.3 BIOBASE Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  149. 7.25.4 BIOBASE Biological Sample Cryopreservation Product Portfolio
  150. 7.25.5 BIOBASE Recent Developments
  151. 7.26 Genepoint Technologies
  152. 7.26.1 Genepoint Technologies Company Information
  153. 7.26.2 Genepoint Technologies Business Overview
  154. 7.26.3 Genepoint Technologies Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Genepoint Technologies Biological Sample Cryopreservation Product Portfolio
  156. 7.26.5 Genepoint Technologies Recent Developments
  157. 7.27 Origincell Biological Cryo Equipment
  158. 7.27.1 Origincell Biological Cryo Equipment Company Information
  159. 7.27.2 Origincell Biological Cryo Equipment Business Overview
  160. 7.27.3 Origincell Biological Cryo Equipment Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Origincell Biological Cryo Equipment Biological Sample Cryopreservation Product Portfolio
  162. 7.27.5 Origincell Biological Cryo Equipment Recent Developments
  163. 7.28 Basecare Medical
  164. 7.28.1 Basecare Medical Company Information
  165. 7.28.2 Basecare Medical Business Overview
  166. 7.28.3 Basecare Medical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Basecare Medical Biological Sample Cryopreservation Product Portfolio
  168. 7.28.5 Basecare Medical Recent Developments
  169. 7.29 Hamilton Company
  170. 7.29.1 Hamilton Company Company Information
  171. 7.29.2 Hamilton Company Business Overview
  172. 7.29.3 Hamilton Company Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  173. 7.29.4 Hamilton Company Biological Sample Cryopreservation Product Portfolio
  174. 7.29.5 Hamilton Company Recent Developments
  175. 7.30 LiCONiC
  176. 7.30.1 LiCONiC Company Information
  177. 7.30.2 LiCONiC Business Overview
  178. 7.30.3 LiCONiC Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  179. 7.30.4 LiCONiC Biological Sample Cryopreservation Product Portfolio
  180. 7.30.5 LiCONiC Recent Developments
  181. 7.31 ASKION
  182. 7.31.1 ASKION Company Information
  183. 7.31.2 ASKION Business Overview
  184. 7.31.3 ASKION Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  185. 7.31.4 ASKION Biological Sample Cryopreservation Product Portfolio
  186. 7.31.5 ASKION Recent Developments
  187. 7.32 SPT Labtech
  188. 7.32.1 SPT Labtech Company Information
  189. 7.32.2 SPT Labtech Business Overview
  190. 7.32.3 SPT Labtech Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  191. 7.32.4 SPT Labtech Biological Sample Cryopreservation Product Portfolio
  192. 7.32.5 SPT Labtech Recent Developments
  193. 7.33 B Medical Systems
  194. 7.33.1 B Medical Systems Company Information
  195. 7.33.2 B Medical Systems Business Overview
  196. 7.33.3 B Medical Systems Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  197. 7.33.4 B Medical Systems Biological Sample Cryopreservation Product Portfolio
  198. 7.33.5 B Medical Systems Recent Developments
  199. 7.34 Custom Biogenic Systems
  200. 7.34.1 Custom Biogenic Systems Company Information
  201. 7.34.2 Custom Biogenic Systems Business Overview
  202. 7.34.3 Custom Biogenic Systems Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  203. 7.34.4 Custom Biogenic Systems Biological Sample Cryopreservation Product Portfolio
  204. 7.34.5 Custom Biogenic Systems Recent Developments
  205. 7.35 IC Biomedical
  206. 7.35.1 IC Biomedical Company Information
  207. 7.35.2 IC Biomedical Business Overview
  208. 7.35.3 IC Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  209. 7.35.4 IC Biomedical Biological Sample Cryopreservation Product Portfolio
  210. 7.35.5 IC Biomedical Recent Developments
  211. 7.36 Cryo Bio System
  212. 7.36.1 Cryo Bio System Company Information
  213. 7.36.2 Cryo Bio System Business Overview
  214. 7.36.3 Cryo Bio System Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  215. 7.36.4 Cryo Bio System Biological Sample Cryopreservation Product Portfolio
  216. 7.36.5 Cryo Bio System Recent Developments
  217. 7.37 Stirling Ultracold
  218. 7.37.1 Stirling Ultracold Company Information
  219. 7.37.2 Stirling Ultracold Business Overview
  220. 7.37.3 Stirling Ultracold Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  221. 7.37.4 Stirling Ultracold Biological Sample Cryopreservation Product Portfolio
  222. 7.37.5 Stirling Ultracold Recent Developments
  223. 7.38 Helmer Scientific
  224. 7.38.1 Helmer Scientific Company Information
  225. 7.38.2 Helmer Scientific Business Overview
  226. 7.38.3 Helmer Scientific Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  227. 7.38.4 Helmer Scientific Biological Sample Cryopreservation Product Portfolio
  228. 7.38.5 Helmer Scientific Recent Developments
  229. 7.39 Micronic
  230. 7.39.1 Micronic Company Information
  231. 7.39.2 Micronic Business Overview
  232. 7.39.3 Micronic Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  233. 7.39.4 Micronic Biological Sample Cryopreservation Product Portfolio
  234. 7.39.5 Micronic Recent Developments
  235. 7.40 OriGen Biomedical
  236. 7.40.1 OriGen Biomedical Company Information
  237. 7.40.2 OriGen Biomedical Business Overview
  238. 7.40.3 OriGen Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  239. 7.40.4 OriGen Biomedical Biological Sample Cryopreservation Product Portfolio
  240. 7.40.5 OriGen Biomedical Recent Developments
  241. 7.41 BINDER
  242. 7.41.1 BINDER Company Information
  243. 7.41.2 BINDER Business Overview
  244. 7.41.3 BINDER Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  245. 7.41.4 BINDER Biological Sample Cryopreservation Product Portfolio
  246. 7.41.5 BINDER Recent Developments
  247. 7.42 Liebherr
  248. 7.42.1 Liebherr Company Information
  249. 7.42.2 Liebherr Business Overview
  250. 7.42.3 Liebherr Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  251. 7.42.4 Liebherr Biological Sample Cryopreservation Product Portfolio
  252. 7.42.5 Liebherr Recent Developments
  253. 7.43 Esco Lifesciences
  254. 7.43.1 Esco Lifesciences Company Information
  255. 7.43.2 Esco Lifesciences Business Overview
  256. 7.43.3 Esco Lifesciences Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  257. 7.43.4 Esco Lifesciences Biological Sample Cryopreservation Product Portfolio
  258. 7.43.5 Esco Lifesciences Recent Developments
  259. 7.44 Cryopal
  260. 7.44.1 Cryopal Company Information
  261. 7.44.2 Cryopal Business Overview
  262. 7.44.3 Cryopal Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  263. 7.44.4 Cryopal Biological Sample Cryopreservation Product Portfolio
  264. 7.44.5 Cryopal Recent Developments
  265. 7.45 Cryotherm
  266. 7.45.1 Cryotherm Company Information
  267. 7.45.2 Cryotherm Business Overview
  268. 7.45.3 Cryotherm Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  269. 7.45.4 Cryotherm Biological Sample Cryopreservation Product Portfolio
  270. 7.45.5 Cryotherm Recent Developments
  271. 7.46 Cryo Diffusion
  272. 7.46.1 Cryo Diffusion Company Information
  273. 7.46.2 Cryo Diffusion Business Overview
  274. 7.46.3 Cryo Diffusion Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  275. 7.46.4 Cryo Diffusion Biological Sample Cryopreservation Product Portfolio
  276. 7.46.5 Cryo Diffusion Recent Developments
  277. 7.47 Statebourne Cryogenics
  278. 7.47.1 Statebourne Cryogenics Company Information
  279. 7.47.2 Statebourne Cryogenics Business Overview
  280. 7.47.3 Statebourne Cryogenics Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  281. 7.47.4 Statebourne Cryogenics Biological Sample Cryopreservation Product Portfolio
  282. 7.47.5 Statebourne Cryogenics Recent Developments
  283. 7.48 Celltrio
  284. 7.48.1 Celltrio Company Information
  285. 7.48.2 Celltrio Business Overview
  286. 7.48.3 Celltrio Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  287. 7.48.4 Celltrio Biological Sample Cryopreservation Product Portfolio
  288. 7.48.5 Celltrio Recent Developments
  289. 7.49 ThermoGenesis
  290. 7.49.1 ThermoGenesis Company Information
  291. 7.49.2 ThermoGenesis Business Overview
  292. 7.49.3 ThermoGenesis Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  293. 7.49.4 ThermoGenesis Biological Sample Cryopreservation Product Portfolio
  294. 7.49.5 ThermoGenesis Recent Developments
  295. 7.50 Jiangsu SERLNG
  296. 7.50.1 Jiangsu SERLNG Company Information
  297. 7.50.2 Jiangsu SERLNG Business Overview
  298. 7.50.3 Jiangsu SERLNG Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  299. 7.50.4 Jiangsu SERLNG Biological Sample Cryopreservation Product Portfolio
  300. 7.50.5 Jiangsu SERLNG Recent Developments
  301. 7.51 SYLAB
  302. 7.51.1 SYLAB Company Information
  303. 7.51.2 SYLAB Business Overview
  304. 7.51.3 SYLAB Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  305. 7.51.4 SYLAB Biological Sample Cryopreservation Product Portfolio
  306. 7.51.5 SYLAB Recent Developments
  307. 7.52 Consarctic
  308. 7.52.1 Consarctic Company Information
  309. 7.52.2 Consarctic Business Overview
  310. 7.52.3 Consarctic Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  311. 7.52.4 Consarctic Biological Sample Cryopreservation Product Portfolio
  312. 7.52.5 Consarctic Recent Developments
  313. 7.53 PromoCell
  314. 7.53.1 PromoCell Company Information
  315. 7.53.2 PromoCell Business Overview
  316. 7.53.3 PromoCell Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  317. 7.53.4 PromoCell Biological Sample Cryopreservation Product Portfolio
  318. 7.53.5 PromoCell Recent Developments
  319. 7.54 FertiPro
  320. 7.54.1 FertiPro Company Information
  321. 7.54.2 FertiPro Business Overview
  322. 7.54.3 FertiPro Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  323. 7.54.4 FertiPro Biological Sample Cryopreservation Product Portfolio
  324. 7.54.5 FertiPro Recent Developments
  325. 7.55 CryoLogic
  326. 7.55.1 CryoLogic Company Information
  327. 7.55.2 CryoLogic Business Overview
  328. 7.55.3 CryoLogic Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  329. 7.55.4 CryoLogic Biological Sample Cryopreservation Product Portfolio
  330. 7.55.5 CryoLogic Recent Developments
  331. 7.56 Cryofab
  332. 7.56.1 Cryofab Company Information
  333. 7.56.2 Cryofab Business Overview
  334. 7.56.3 Cryofab Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  335. 7.56.4 Cryofab Biological Sample Cryopreservation Product Portfolio
  336. 7.56.5 Cryofab Recent Developments
8 North America
  1. 8.1 North America Biological Sample Cryopreservation Revenue (2021-2032)
  2. 8.2 North America Biological Sample Cryopreservation Revenue by Type (2021-2032)
  3. 8.2.1 North America Biological Sample Cryopreservation Revenue by Type (2021-2026)
  4. 8.2.2 North America Biological Sample Cryopreservation Revenue by Type (2027-2032)
  5. 8.3 North America Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
  6. 8.4 North America Biological Sample Cryopreservation Revenue by Application (2021-2032)
  7. 8.4.1 North America Biological Sample Cryopreservation Revenue by Application (2021-2026)
  8. 8.4.2 North America Biological Sample Cryopreservation Revenue by Application (2027-2032)
  9. 8.5 North America Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
  10. 8.6 North America Biological Sample Cryopreservation Revenue by Country
  11. 8.6.1 North America Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biological Sample Cryopreservation Revenue by Country (2021-2026)
  13. 8.6.3 North America Biological Sample Cryopreservation Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biological Sample Cryopreservation Revenue (2021-2032)
  2. 9.2 Europe Biological Sample Cryopreservation Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biological Sample Cryopreservation Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biological Sample Cryopreservation Revenue by Type (2027-2032)
  5. 9.3 Europe Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biological Sample Cryopreservation Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biological Sample Cryopreservation Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biological Sample Cryopreservation Revenue by Application (2027-2032)
  9. 9.5 Europe Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biological Sample Cryopreservation Revenue by Country
  11. 9.6.1 Europe Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biological Sample Cryopreservation Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biological Sample Cryopreservation Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biological Sample Cryopreservation Revenue (2021-2032)
  2. 10.2 China Biological Sample Cryopreservation Revenue by Type (2021-2032)
  3. 10.2.1 China Biological Sample Cryopreservation Revenue by Type (2021-2026)
  4. 10.2.2 China Biological Sample Cryopreservation Revenue by Type (2027-2032)
  5. 10.3 China Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
  6. 10.4 China Biological Sample Cryopreservation Revenue by Application (2021-2032)
  7. 10.4.1 China Biological Sample Cryopreservation Revenue by Application (2021-2026)
  8. 10.4.2 China Biological Sample Cryopreservation Revenue by Application (2027-2032)
  9. 10.5 China Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biological Sample Cryopreservation Revenue (2021-2032)
  2. 11.2 Asia Biological Sample Cryopreservation Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biological Sample Cryopreservation Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biological Sample Cryopreservation Revenue by Type (2027-2032)
  5. 11.3 Asia Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biological Sample Cryopreservation Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biological Sample Cryopreservation Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biological Sample Cryopreservation Revenue by Application (2027-2032)
  9. 11.5 Asia Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biological Sample Cryopreservation Revenue by Country
  11. 11.6.1 Asia Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biological Sample Cryopreservation Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biological Sample Cryopreservation Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biological Sample Cryopreservation Revenue (2021-2032)
  2. 12.2 SAMEA Biological Sample Cryopreservation Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biological Sample Cryopreservation Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biological Sample Cryopreservation Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biological Sample Cryopreservation Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biological Sample Cryopreservation Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biological Sample Cryopreservation Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biological Sample Cryopreservation Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biological Sample Cryopreservation Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biological Sample Cryopreservation Revenue by Country
  11. 12.6.1 SAMEA Biological Sample Cryopreservation Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biological Sample Cryopreservation Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biological Sample Cryopreservation Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.